Skip to main content
. Author manuscript; available in PMC: 2010 Nov 15.
Published in final edited form as: Am J Cardiol. 2009 Sep 26;104(10):1343–1350. doi: 10.1016/j.amjcard.2009.07.003

Table 3.

Heart rate (HR) and beta blocker use. Entries represent mean values, while values in parentheses represent range for continuous variables and percentages for counts.

Helical-only Strategy (n=138) Sequential-if-appropriate Strategy (n=261) P Value Helical Protocol (n=174) Sequential Protocol (n=225) P Value Helical Protocol in Sequential-if-appropriate Strategy (n=36) Sequential Protocol in Sequential-if-appropriate Strategy (n=225) P Value
Initial HR (bpm) 68.0 (40–113) 66.7 (40–108) 0.34 70.9 (40–113) 64.5 (40–94) <0.001 80.6 (58–108) 64.5 (40–95) <0.001
HR after any metoprolol (bpm) 63.1 (40–113) 60.9 (40–102) 0.045 65.6 (40–113) 58.8 (40–79) <0.001 74.4 (58–102) 58.8 (40–79) <0.001
End HR75 8 (6.5%) 18 (7.0%) 0.69 22 (13.8%) 4 (1.8%) <0.001 14 (38.9%) 4 (1.8%) <0.001
Change in HR in those given beta blockers (bpm) 11.2 9.2 0.037 11.1 8.8 0.026 10.9 8.8 0.34
Beta blocker use 70 (50.7%) 161 (61.7%) 0.035 93 (53.5%) 138 (61.3%) 0.11 23 (63.9%) 138 (61.3%) 0.77
Beta blocker dose (mg) 4.1 6.7 0.001 5.3 6.2 0.070 9.6 6.2 0.048